0
0

Department of Health and Human Services Awarded a Contract to BRILLIENT CORPORATION for $480,836.70

Signed on

4/13/2022, 12:00 AM

BRILLIENT CORPORATION Government Contract #75F40122F19212

BRILLIENT CORPORATION was awarded a contract with the United States Government for $480,836.70. The contract was awarded by the agency office FDA OFFICE OF ACQ GRANT SVCS, which is a division with the Food and Drug Administration within the Department of Health and Human Services.

Summary of Award

The US federal government awarded a contract to Brillient Corporation for time and materials award services to provide FDA communications strategy for the Immediate Office of the Commissioner. The contract, with a total obligation of $480,836.70, was signed on April 13, 2022, and includes base exercised options for the same amount. The contract falls under the category of a BPA call.

The parent award agency is the Department of Health and Human Services, specifically the Food and Drug Administration (FDA). The contract falls under a Blanket Purchase Agreement (BPA) with a single award. The contract is for professional and technical services under the program acronym "PROFESSIONAL AND TECHNICAL SERVICES BLANKET PURCHASE AGREEMENT."

The recipient of the contract, Brillient Corporation, is a U.S.-owned business located in Reston, Virginia. The company offers various services and holds multiple business categories, including being a minority-owned business, a small disadvantaged business, and a Subchapter S Corporation. The contract period of performance is from April 13, 2022, to June 30, 2025, with a potential end date of June 30, 2025. The contract involves support services in the professional category, specifically under the product or service code "SUPPORT- PROFESSIONAL: OTHER." The contract was awarded through full and open competition, with no preference used in the evaluation process. The contract pricing is based on time and materials. The contract is not part of a multi-year contract and is not consolidated. The contract was not awarded through a competitive set-aside. The contract officers from Brillient Corporation include Sukumar R Iyer, Richard Jacik, Paul J Kolebuck, Greg D Cioffi, and Tammy S McChain, with varying amounts allocated to each officer for their roles in the contract. The place of performance for the contract is in Rockville, Maryland, with a congressional code of 08. The contract falls under the Professional Services category, specifically under the subcategory of Administrative Management and General Management Consulting Services. Overall, the contract between the US federal government and Brillient Corporation for FDA communications strategy services is a significant agreement that will span over several years, providing essential support to the FDA's communication efforts.

Contract Details

Contract ID75F40122F19212
Contract TypeA
Total Obligation$480,836.70
Exercised Options$480,836.70
Base Amount + Options$480,836.70
Date Signed2022-04-13
Contract DescriptionTIME AND MATERIALS AWARD SERVICES TO PROVIDE FDA COMMUNICATIONS STRATEGY FOR THE IMMEDIATE OFFICE OF THE COMMISSIONER COR: BONNIE N. ANDERSON TELEPHONE NUMBER: 202-731-7594 EMAIL ADDRESS: BONNIE.ANDERSON@FDA.HHS.GOV NOTICE TO PRO
Start Date2022-04-13
End Date2025-06-30

Agency Details

Awarding AgencyDepartment of Health and Human Services
Awarding Sub AgencyFood and Drug Administration
Awarding OfficeFDA OFFICE OF ACQ GRANT SVCS
Funding AgencyDepartment of Health and Human Services
Funding Sub AgencyFood and Drug Administration
Funding OfficeFDA OFFICE OF ACQ GRANT SVCS

Recipient Details

RecipientBRILLIENT CORPORATION
Recipient Location1893 METRO CENTER DR STE 210 RESTON VIRGINIA, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Minority Owned Business, Not Designated a Small Business, Self-Certified Small Disadvantaged Business, Small Business, Special Designations, Subchapter S Corporation, Indian (Subcontinent) American Owned Business, U.S.-Owned Business

Comments

Award Transactions